Saline Injection - Assisted Anesthesia in Eyelid Surgery
This study is currently recruiting participants.
Verified August 2011 by Sheba Medical Center
Sponsor:
Sheba Medical Center
Information provided by:
Sheba Medical Center
ClinicalTrials.gov Identifier:
NCT01239498
First received: November 2, 2010
Last updated: August 7, 2011
Last verified: August 2011
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
The investigators hypothesize that injection of saline to the upper eyelids prior to lidocaine/adrenaline injection will reduce pain of the local anesthetic in comparison to injection of lidocaine alone.
| Condition | Intervention | Phase |
|---|---|---|
|
Blepharoptosis |
Procedure: Injection of Saline + Lidocaine/Adrenaline Procedure: Lidocaine/Adrenaline only |
Phase 4 |
| Study Type: | Interventional |
| Study Design: | Allocation: Randomized Intervention Model: Single Group Assignment Masking: Open Label Primary Purpose: Treatment |
| Official Title: | Saline Injection - Assisted Anesthesia in Eyelid Surgery |
Resource links provided by NLM:
Drug Information available for:
Epinephrine bitartrate
Epinephrine
Epinephrine hydrochloride
Lidocaine hydrochloride
Lidocaine
Racepinephrine hydrochloride
Racepinephrine
U.S. FDA Resources
Further study details as provided by Sheba Medical Center:
Primary Outcome Measures:
- Patients' verbal pain scores will be elicited and documented immediately by the oculoplastic fellow [ Time Frame: 1-2 minutes ] [ Designated as safety issue: No ]
| Estimated Enrollment: | 60 |
| Study Start Date: | November 2010 |
| Estimated Study Completion Date: | December 2011 |
| Estimated Primary Completion Date: | October 2011 (Final data collection date for primary outcome measure) |
| Arms | Assigned Interventions |
|---|---|
| Experimental: Saline + Lidocaine/Adrenaline |
Procedure: Injection of Saline + Lidocaine/Adrenaline
All anaesthetic injections will consist of xylocaine 1% with 1:100,000 adrenaline and will be administered through a short 30 Gauge needle at a constant slow speed at multiple (6-7) sites along the upper lid by a single oculoplastic consultant. The experimental eyelid will receive a saline-consisted injection 0.5cc prior to the administration of the anesthetic injection. Injection of Saline + Lidocaine 1% Other Name: Local eyelid anesthesia
|
| Placebo Comparator: Lidocaine/Adrenaline only |
Procedure: Lidocaine/Adrenaline only
Injection of Lidocaine/Adrenaline only
Other Name: Local eyelid anesthesia
|
Show Detailed Description
Eligibility| Ages Eligible for Study: | 18 Years and older |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | Yes |
Criteria
Inclusion Criteria:
- patients undergoing bilateral upper eyelid surgery under local anaesthetic who have given fully informed consent to be in the trial
Exclusion Criteria:
- Previous upper eyelid surgery
Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT01239498
Contacts
| Contact: Ido Didi Fabian, MD | +972547830444 | didifabian@gmail.com |
Locations
| Israel | |
| Goldschleger institute of ophthalmology, Sheba medical center | Not yet recruiting |
| Ramat Gan, Israel | |
| Contact: Ido Didi Fabian, MD +972547830444 didifabian@gmail.com | |
| Goldschlager eye institute | Recruiting |
| Ramat Gan, Israel | |
| Contact: Ido Ido Fabian, MD didifabian@gmail.com | |
Sponsors and Collaborators
Sheba Medical Center
Investigators
| Study Chair: | Ido Didi Fabian, MD | Sheba medical center, Goldschleger institute |
More Information
Publications:
| Responsible Party: | Ido Didi Fabian MD, Sheba medical center |
| ClinicalTrials.gov Identifier: | NCT01239498 History of Changes |
| Other Study ID Numbers: | SHEBA-10-8246-DF-CTIL |
| Study First Received: | November 2, 2010 |
| Last Updated: | August 7, 2011 |
| Health Authority: | Israel: Ministry of Health |
Additional relevant MeSH terms:
|
Eyelid Diseases Blepharoptosis Eye Diseases Epinephrine Epinephryl borate Lidocaine Anesthetics Adrenergic beta-Agonists Adrenergic Agonists Adrenergic Agents Neurotransmitter Agents Molecular Mechanisms of Pharmacological Action Pharmacologic Actions Physiological Effects of Drugs Bronchodilator Agents |
Autonomic Agents Peripheral Nervous System Agents Anti-Asthmatic Agents Respiratory System Agents Therapeutic Uses Mydriatics Adrenergic alpha-Agonists Sympathomimetics Vasoconstrictor Agents Cardiovascular Agents Central Nervous System Depressants Central Nervous System Agents Anesthetics, Local Sensory System Agents Anti-Arrhythmia Agents |
ClinicalTrials.gov processed this record on June 18, 2013